E D Aĭngorn

452 total citations
9 papers, 380 citations indexed

About

E D Aĭngorn is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, E D Aĭngorn has authored 9 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Cell Biology. Recurrent topics in E D Aĭngorn's work include Proteoglycans and glycosaminoglycans research (3 papers), Fibroblast Growth Factor Research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). E D Aĭngorn is often cited by papers focused on Proteoglycans and glycosaminoglycans research (3 papers), Fibroblast Growth Factor Research (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). E D Aĭngorn collaborates with scholars based in Israel, United States and Russia. E D Aĭngorn's co-authors include Michael Elkin, Hua‐Quan Miao, Israël Vlodavsky, Cy A. Stein, Rivka Ishai-Michaeli, Arnon Nagler, Mark Pines, Reuven Reich, Shmuel A. Ben‐Sasson and David M. Ornitz and has published in prestigious journals such as Journal of Clinical Investigation, The FASEB Journal and International Journal of Cancer.

In The Last Decade

E D Aĭngorn

8 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E D Aĭngorn Israel	6	242	154	68	56	50	9	380
Kazuhisa Minamiguchi Japan	12	145 0.6×	55 0.4×	35 0.5×	40 0.7×	74 1.5×	25	404
Anna Bezos Australia	9	251 1.0×	99 0.6×	98 1.4×	70 1.3×	56 1.1×	14	450
Zohar M. Merchant United States	9	289 1.2×	277 1.8×	129 1.9×	13 0.2×	32 0.6×	12	402
Yuri Kusano Japan	10	313 1.3×	269 1.7×	19 0.3×	52 0.9×	105 2.1×	14	490
Chien‐Hui Lieu Taiwan	8	223 0.9×	103 0.7×	12 0.2×	107 1.9×	38 0.8×	12	390
Rajinder S. Sawhney United States	13	342 1.4×	115 0.7×	47 0.7×	61 1.1×	55 1.1×	27	564
Ashik Jawahar Deen Finland	13	483 2.0×	180 1.2×	51 0.8×	47 0.8×	148 3.0×	15	640
Michio Iwahana Japan	11	257 1.1×	49 0.3×	67 1.0×	141 2.5×	77 1.5×	19	419
Manoj Kumar Karuppusamy Rathinam United States	6	453 1.9×	52 0.3×	16 0.2×	157 2.8×	144 2.9×	7	657
James A. Mezick United States	12	208 0.9×	170 1.1×	13 0.2×	14 0.3×	16 0.3×	23	474

Countries citing papers authored by E D Aĭngorn

Since Specialization

Citations

This map shows the geographic impact of E D Aĭngorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E D Aĭngorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E D Aĭngorn more than expected).

Fields of papers citing papers by E D Aĭngorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E D Aĭngorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E D Aĭngorn. The network helps show where E D Aĭngorn may publish in the future.

Co-authorship network of co-authors of E D Aĭngorn

This figure shows the co-authorship network connecting the top 25 collaborators of E D Aĭngorn. A scholar is included among the top collaborators of E D Aĭngorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E D Aĭngorn. E D Aĭngorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Aĭngorn, E D, et al.. (2005). Chromosome Trisomy 18 Syndrome. PubMed. 51(3). 638–641.

2.

Elkin, Michael, Hua‐Quan Miao, Arnon Nagler, et al.. (2000). Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. The FASEB Journal. 14(15). 2477–2485. 90 indexed citations

3.

Miao, Hua‐Quan, et al.. (1999). Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. International Journal of Cancer. 83(3). 424–431. 151 indexed citations

4.

Elkin, Michael, Reuven Reich, Arnon Nagler, et al.. (1999). Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone.. PubMed. 5(8). 1982–8. 61 indexed citations

5.

Miao, Hua‐Quan, et al.. (1999). Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. International Journal of Cancer. 83(3). 424–431. 5 indexed citations

6.

Miao, Hui, David M. Ornitz, E D Aĭngorn, Shmuel A. Ben‐Sasson, & Israël Vlodavsky. (1997). Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.. Journal of Clinical Investigation. 99(7). 1565–1575. 66 indexed citations

7.

Nv, Perova, et al.. (1990). [Indicators of the lipoprotein spectrum in adolescents with primary arterial hypotension].. PubMed. 68(2). 54–8. 1 indexed citations

8.

Aĭngorn, E D, et al.. (1985). [Lipids and apoproteins in the blood plasma of children with a hereditary disposition to ischemic heart disease].. PubMed. 25(5). 76–81. 1 indexed citations

9.

Aĭngorn, E D, et al.. (1972). DNA synthesis related to genome activation in human lymphocytes cultured in vitro. Experimental Cell Research. 75(2). 369–378. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact